Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia Unveils New Enhancements to its Digital Pathology Platform

Proscia
By Author Proscia | October 12, 2022

Proscia, a leading provider of digital and computational pathology solutions, has introduced the next version of its Concentriq® Dx platform for primary diagnostic workflows, which is CE-marked under IVDR.

Our website uses cookies. By using this site, you agree to its use of cookies.